Height and pancreatic cancer risk: A systematic review and meta-analysis of cohort studies

Cancer Causes and Control

Volumn 23, Issue 8, 2012, Pages 1213-1222

  Aune, Dagfinn ^a   Vieira, Ana Rita ^a   Chan, Doris Sau Man ^a   Rosenblatt, Deborah A Navarro ^a   Vieira, Rui ^a   Greenwood, Darren C ^b   Cade, Janet E ^b   Burley, Victoria J ^b   Norat, Teresa ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Height; Meta analysis; Pancreatic cancer; Systematic review; The Continuous Update Project

Indexed keywords

ADULT; AGED; BODY HEIGHT; CANCER RISK; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SELF REPORT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BODY HEIGHT; COHORT STUDIES; FEMALE; HUMANS; MALE; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS;

EID: 84864876753     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9983-0     Document Type: Review

References (53)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990 s. Eur J Cancer 44:1345-1389
3. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB (2008) Tobacco and the risk of pancreatic cancer: a review and metaanalysis. Langenbecks Arch Surg 393:535-545
4. Fuchs CS, Colditz GA, Stampfer MJ et al (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156:2255-2260
5. Permuth-Wey J, Egan KM (2009) Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 8:109-117
6. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24:349-358
7. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076-2083
8. Aune D, Greenwood DC, Chan DS et al (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23(4):843-852
9. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. AICR, Washington DC
10. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785-794
11. Silventoinen K (2003) Determinants of variation in adult body height. J Biosoc Sci 35:263-285
12. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313-342
13. Berrington de Gonzalez A, Bueno-de-Mesquita HB, Roddam A et al (2006) Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15: 879-885
14. Verhage BA, Schouten LJ, Goldbohm RA, van den Brandt PA (2007) Anthropometry and pancreatic cancer risk: an illustration of the importance of microscopic verification. Cancer Epidemiol Biomarkers Prev 16:1449-1454
15. Berrington de Gonzalez A, Yun JE, Lee SY, Klein AP, Jee SH (2008) Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 17:359-364
16. Meinhold CL, Berrington de Gonzalez A, Albanes D et al (2009) Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers. Cancer Causes Control 20:681-690
17. Stevens RJ, Roddam AW, Spencer EA et al (2009) Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int J Cancer 124:2400-2405
18. Genkinger JM, Spiegelman D, Anderson KE et al (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 129(7):1708-1717
19. Arslan AA, Helzlsouer KJ, Kooperberg C et al (2010) Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791-802
20. Batty GD, Barzi F, Woodward M et al (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646-654
21. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012
22. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6:863-873
23. Nilsen TI, Vatten LJ (2000) A prospective study of lifestyle factors and the risk of pancreatic cancer in Nord-Trondelag, Norway. Cancer Causes Control 11:645-652
24. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Stampfer MJ, Fuchs CS (2001) Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286:921-929
25. Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey SG (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157-166
26. Stolzenberg-Solomon RZ, Adams K, Leitzmann M et al (2008) Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am J Epidemiol 167:586-597
27. Luo J, Margolis KL, Adami HO, Lacroix A, Ye W (2008) Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer 99:527-531
28. Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S (2009) Height and site-specific cancer risk: A cohort study of a Korean adult population. Am J Epidemiol 170:53-64
29. Ogren M, Hedberg M, Berglund G, Borgstrom A, Janzon L (1996) Risk of pancreatic carcinoma in smokers enhanced by weight gain. Results from 10-year follow-up of the Malmo preventive Project Cohort Study. Int J Pancreatol 20:95-101
30. Robsahm TE, Tretli S (1999) Height, weight and gastrointestinal cancer: a follow-up study in Norway. Eur J Cancer Prev 8: 105-113
31. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D (2002) A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 13:417-426
32. Stolzenberg-Solomon RZ, Limburg P, Pollak M, Taylor PR, Virtamo J, Albanes D (2004) Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev 13:438-444
33. Giovannucci E, Rimm EB, Liu Y, Willett WC (2004) Height, predictors of C-peptide and cancer risk in men. Int J Epidemiol 33:217-225
34. Song YM, Smith GD, Sung J (2003) Adult height and causespecific mortality: a large prospective study of South Korean men. Am J Epidemiol 158:479-485
35. Song YM, Sung J (2008) Adult height and the risk of mortality in South Korean women. Am J Epidemiol 168:497-505
36. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
37. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301-1309
38. Chene G, Thompson SG (1996) Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. Am J Epidemiol 144:610-621
39. Royston P (2000) A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 19:1831-1847
40. Bagnardi V, Zambon A, Quatto P, Corrao G (2004) Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol 159:1077-1086
41. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
42. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634
43. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101
44. Cairns BJ, Liu B, Clennell S et al (2011) Lifetime body size and reproductive factors: comparisons of data recorded prospectively with self reports in middle age. BMC Med Res Methodol 11:7
45. Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ (1988) Accuracy and reliability of self-measurement of body girths. Am J Epidemiol 128:740-748
46. Spencer EA, Appleby PN, Davey GK, Key TJ (2002) Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5:561-565
47. Berkey CS, Colditz GA, Rockett HR, Frazier AL, Willett WC (2009) Dairy consumption and female height growth: prospective cohort study. Cancer Epidemiol Biomarkers Prev 18:1881-1887
48. Rogers I, Emmett P, Gunnell D, Dunger D, Holly J (2006) Milk as a food for growth? The insulin-like growth factors link. Public Health Nutr 9:359-368
49. Rogers I, Metcalfe C, Gunnell D, Emmett P, Dunger D, Holly J (2006) Insulin-like growth factor-I and growth in height, leg length, and trunk length between ages 5 and 10 years. J Clin Endocrinol Metab 91:2514-2519
50. LeRoith D, Roberts CT Jr. (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127-137
51. Douglas JB, Silverman DT, Pollak MN, Tao Y, Soliman AS, Stolzenberg-Solomon RZ (2010) Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 19:2298-2306
52. Lin Y, Tamakoshi A, Kikuchi S et al (2004) Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110:584-588
53. Wolpin BM, Michaud DS, Giovannucci EL et al (2007) Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer 97:98-104